Clinical Trial

Assessing Patient Comfort, Anxiety, and Satisfaction During CR Comparing Conventional Drops With ROC

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2025 (before its estimated June 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the efficacy of conventional cycloplegic agents, such as cyclopentolate, with rapid-onset cycloplegics, like a combination of tropicamide and phenylephrine, in reducing patient anxiety and discomfort during cycloplegic refraction. Cycloplegic refraction is an essential procedure for diagnosing refractive errors, particularly in children, by temporarily paralyzing the ciliary muscle to inhibit accommodation. While cyclopentolate has a relatively quick onset, tropicamide is preferred due to its faster onset and shorter duration. Despite its advantages, concerns about patient discomfort and anxiety during the procedure remain, especially in pediatric populations.
Trial Details
NCT Number NCT06914063
Lead Sponsor Superior University
Conditions Cycloplegic Paralysis of Accommodation
Enrollment 74 participants
Start Date 2025-03-20
Primary Completion 2025-06-20 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-06